(S)-(4,4-Difluoropyrrolidin-2-yl)methanol hydrochloride, 95.0%, 25g

2-Chloro-N-o-tolyl-acetamide, 95.0%, 1g

3,5-DIFLUORO-4-(2,2,2-TRIFLUOROETHOXY)BENZALDEHYDE, 97.0%, 1g

Methyl 2-amino-5-(dimethylphosphoryl)benzoate, 98%, 250mg

2-(3-Fluoro-5-nitrophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 96%, 250mg

1-(5-BROMO-3-(TRIFLUOROMETHYL)PYRIDIN-2-YL)HYDRAZINE, 95.0%, 10g

Orange oil, Brazilian, 100 ml, glass packaging

(2S)-2-(9H-Fluoren-9-ylmethoxycarbonylamino)-5-[(2-methylpropan-2-yl)oxy]-4-[(2-methylpropan-2-yl)oxycarbonyl]-5-oxopentanoic acid, 97%, 100mg

Methyl 4-trifluoromethylbenzoylacetate, 95.0%, 25g

Methyl 2-amino-5-(morpholin-4-yl)benzoate, 98%, 2.5g

GC capillary column ROTI®Cap-1, 60 m, 0.32 mm, 1.00 µm, 1 Piece(s)

N-Methoxy-N-methylfuran-2-carboxamide, 95.0%, 5g

2,4,6-Tribromobenzaldehyde, 97%, 250mg